JP2005524719A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005524719A5 JP2005524719A5 JP2004503957A JP2004503957A JP2005524719A5 JP 2005524719 A5 JP2005524719 A5 JP 2005524719A5 JP 2004503957 A JP2004503957 A JP 2004503957A JP 2004503957 A JP2004503957 A JP 2004503957A JP 2005524719 A5 JP2005524719 A5 JP 2005524719A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- amino acids
- polypeptide
- group
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/141,508 US20030215460A1 (en) | 2002-05-07 | 2002-05-07 | Methods and compositions for inducing an immune response |
| PCT/US2002/036206 WO2003096017A1 (en) | 2002-05-07 | 2002-10-21 | Methods and compositions for inducing an immune response |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2005524719A JP2005524719A (ja) | 2005-08-18 |
| JP2005524719A5 true JP2005524719A5 (enExample) | 2006-01-05 |
| JP4299777B2 JP4299777B2 (ja) | 2009-07-22 |
Family
ID=29418406
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004503957A Expired - Fee Related JP4299777B2 (ja) | 2002-05-07 | 2002-10-21 | 免疫応答を誘導するための方法および組成物 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US20030215460A1 (enExample) |
| EP (1) | EP1499886B1 (enExample) |
| JP (1) | JP4299777B2 (enExample) |
| KR (1) | KR100943825B1 (enExample) |
| CN (1) | CN1639569B (enExample) |
| AT (1) | ATE455300T1 (enExample) |
| AU (1) | AU2002365437B2 (enExample) |
| CA (1) | CA2484607A1 (enExample) |
| DE (1) | DE60235122D1 (enExample) |
| DK (1) | DK1499886T3 (enExample) |
| ES (1) | ES2338308T3 (enExample) |
| WO (1) | WO2003096017A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2554370A1 (en) * | 2004-01-26 | 2005-08-25 | Brett Premack | Compositions and methods of use of w-peptides |
| WO2006039511A2 (en) * | 2004-09-30 | 2006-04-13 | Boston Scientific Scimed, Inc. | System and method of obstruction removal |
| US8221995B2 (en) * | 2007-03-23 | 2012-07-17 | Seok-Won Lee | Methods and compositions for diagnosis and/or prognosis in systemic inflammatory response syndromes |
| US20090004755A1 (en) * | 2007-03-23 | 2009-01-01 | Biosite, Incorporated | Methods and compositions for diagnosis and/or prognosis in systemic inflammatory response syndromes |
| AU2010270313B2 (en) * | 2009-07-10 | 2014-05-22 | Transgene Sa | Biomarker for selecting patients and related methods |
| KR101249041B1 (ko) | 2010-04-28 | 2013-03-29 | 포항공과대학교 산학협력단 | 결합조직 성장인자를 이용한 약학적 조성물 |
| EP3122375B1 (en) | 2014-03-28 | 2021-03-03 | University of Washington through its Center for Commercialization | Breast and ovarian cancer vaccines |
| AU2017205270B2 (en) | 2016-01-08 | 2024-01-18 | Nykode Therapeutics ASA | Therapeutic anticancer neoepitope vaccine |
| CN107375922B (zh) * | 2017-07-20 | 2020-06-09 | 南京农业大学 | 一种水溶性复合免疫佐剂及猪圆环病毒病疫苗 |
| JP2019116454A (ja) * | 2017-12-27 | 2019-07-18 | 国立大学法人帯広畜産大学 | アジュバント |
| CN112263674A (zh) * | 2020-11-09 | 2021-01-26 | 天津农学院 | 一种猪3型链球菌荚膜多糖亚单位疫苗及其制备方法与应用 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| US4877611A (en) * | 1986-04-15 | 1989-10-31 | Ribi Immunochem Research Inc. | Vaccine containing tumor antigens and adjuvants |
| US6024983A (en) | 1986-10-24 | 2000-02-15 | Southern Research Institute | Composition for delivering bioactive agents for immune response and its preparation |
| US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
| US5328470A (en) | 1989-03-31 | 1994-07-12 | The Regents Of The University Of Michigan | Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| US5284753A (en) | 1991-03-20 | 1994-02-08 | Neuro Probe, Inc. | Multiple-site chemotactic test apparatus and method |
| EP0633929B1 (en) | 1992-04-01 | 2004-03-03 | The Rockefeller University | METHOD FOR $i(IN VITRO) PROLIFERATION OF DENDRITIC CELL PRECURSORS AND THEIR USE TO PRODUCE IMMUNOGENS |
| US6001606A (en) * | 1994-03-08 | 1999-12-14 | Human Genome Sciences, Inc. | Polynucleotides encoding myeloid progenitor inhibitory factor-1 (MPIF-1) and polypeptides encoded thereby |
| IL113610A0 (en) | 1994-06-03 | 1995-08-31 | Immunomedics Inc | A method of radiolabeling a protein, radiolabeled proteins prepared thereby and diagnostic kits containing the same |
| US5874211A (en) * | 1995-04-13 | 1999-02-23 | Incyte Pharmaceuticals, Inc. | Chemokine expressed in eosinophils |
| JPH11512610A (ja) * | 1995-09-29 | 1999-11-02 | スミスクライン・ビーチャム・コーポレイション | 短縮形ケモカインβ−８ |
| WO1998014582A1 (en) * | 1996-09-30 | 1998-04-09 | Human Genome Sciences, Inc. | Therapeutic compositions and methods for treating disease states with myeloid progenitor inhibitory factor-1 (mpif-1), monocyte colony inhibitory factor (m-cif), and macrophage inhibitory factor-4 (mip-4) |
| DE19913707A1 (de) * | 1999-03-26 | 2000-10-05 | Privates Inst Bioserv Gmbh | Immunadsorber zur Sepsistherapie |
| CA2387545A1 (en) * | 1999-10-14 | 2001-04-19 | Human Genome Sciences, Inc. | Methods of treating or preventing cell, tissue, and organ damage using human myeloid progenitor inhibitory factor-1 (mpif-1) |
| US20030096260A1 (en) * | 2001-10-09 | 2003-05-22 | Zhenhua Miao | Compositions useful as ligands for the formyl peptide receptor like 1 receptor and methods of use thereof |
-
2002
- 2002-05-07 US US10/141,508 patent/US20030215460A1/en not_active Abandoned
- 2002-10-21 ES ES02805706T patent/ES2338308T3/es not_active Expired - Lifetime
- 2002-10-21 KR KR1020047017801A patent/KR100943825B1/ko not_active Expired - Fee Related
- 2002-10-21 AU AU2002365437A patent/AU2002365437B2/en not_active Ceased
- 2002-10-21 EP EP02805706A patent/EP1499886B1/en not_active Expired - Lifetime
- 2002-10-21 WO PCT/US2002/036206 patent/WO2003096017A1/en not_active Ceased
- 2002-10-21 DK DK02805706.5T patent/DK1499886T3/da active
- 2002-10-21 AT AT02805706T patent/ATE455300T1/de active
- 2002-10-21 CN CN028292847A patent/CN1639569B/zh not_active Expired - Fee Related
- 2002-10-21 DE DE60235122T patent/DE60235122D1/de not_active Expired - Lifetime
- 2002-10-21 CA CA002484607A patent/CA2484607A1/en not_active Abandoned
- 2002-10-21 JP JP2004503957A patent/JP4299777B2/ja not_active Expired - Fee Related
-
2005
- 2005-07-05 US US11/175,003 patent/US8637043B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Sewell et al. | Recombinant Listeria vaccines containing PEST sequences are potent immune adjuvants for the tumor-associated antigen human papillomavirus-16 E7 | |
| WO2019002444A9 (en) | NEW T CELL RECEPTORS AND IMMUNOTHERAPY USING THE SAME | |
| JP2016156828A5 (enExample) | ||
| JP2012501959A5 (enExample) | ||
| EP3545965A3 (en) | Novel peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (hcc) and other cancers | |
| WO2006037421A3 (en) | Immunogenic t-helper epitopes from human tumour antigens and immunotherapeutic methods using said epitopes | |
| JP2012509659A5 (enExample) | ||
| ATE461215T1 (de) | Tumor-assoziierte peptide, welche an unterschiedliche menschliche leukozytenantigene der klasse ii binden | |
| EP2562183A8 (en) | Novel immunogenic epitopes for immunotherapy | |
| RU2009118432A (ru) | Пептидные вакцины против рака с экспрессией полипептидов mphosph1 или depdc1 | |
| JP2005524719A5 (enExample) | ||
| HUP0302532A2 (hu) | Petefészekrák terápiájában és diagnosztizálásában alkalmazható készítmények és eljárások | |
| JP2008530975A5 (enExample) | ||
| JP2018536002A5 (enExample) | ||
| JP2014139185A5 (enExample) | ||
| WO2001035989A3 (de) | Verwendung von anti-idiotypische antikörpern als impfstoffe gegenkrebs | |
| CA2634480C (en) | Immunogenic polypeptide composed of tumor antigen-derived optimized cryptic peptides, and uses thereof | |
| TWI455720B (zh) | Ｒａｂ６ｋｉｆｌ／ｋｉｆ２０ａ抗原決定位胜肽及含此胜肽的疫苗 | |
| WO2010107116A1 (ja) | Ｓｏｘ２由来のｈｌａ－ａ２４結合性癌抗原ペプチド | |
| Velders et al. | Identification of peptides for immunotherapy of cancer. It is still worth the effort | |
| JP2008531463A5 (enExample) | ||
| SE0000597D0 (sv) | Novel antibody | |
| CN103254313B (zh) | 组合的ctl抗原表位及其应用 | |
| RU2017106889A (ru) | Пептид, полученный из urlc10, и содержащая его вакцина | |
| JP2006501166A5 (enExample) |